Skip to main content
CYCLOPHARM LIMITED logo

CYCLOPHARM LIMITED — Investor Relations & Filings

Ticker · CYC ISIN · AU000000CYC5 LEI · 9845008C9R4608FB7007 ASX Manufacturing
Filings indexed 777 across all filing types
Latest filing 2007-01-16 Regulatory Filings
Country AU Australia
Listing ASX CYC

About CYCLOPHARM LIMITED

https://www.cyclopharm.com.au

Cyclopharm Limited focuses on the development and commercialization of specialized medical imaging technologies. Its primary product, Technegas, is an ultra-fine dispersion of carbon nano-particles labeled with Technetium-99m, utilized for functional lung ventilation imaging. This technology is used to diagnose Pulmonary Embolism by providing high-resolution images via the inhalation of a radioactive aerosol. Technegas is generated on-site using proprietary equipment and is compatible with SPECT and SPECT/CT imaging. The system is engineered to provide diagnostic clarity even in patients with underlying airway diseases. Beyond its primary diagnostic use, the company investigates applications for its technology in managing chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.

Recent filings

Filing Released Lang Actions
Amended notice re Admission to Official List 1 page
Regulatory Filings Classification · 95% confidence The document is a market release announcing the admission of Cyclopharm Limited to the Official List of ASX Limited, including details about the commencement of official quotation of shares. It is an announcement related to the listing of securities on the stock exchange, which corresponds to a regulatory announcement about capital market status rather than a financial report or detailed filing. The document is short and does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2007-01-16 English
Media Release 4 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an ASX and media release dated January 17, 2007, announcing the initial public offering (IPO) and listing of Cyclopharm Limited on the Australian Stock Exchange. It discusses the company's business, market position, and future plans, including financial forecasts and strategic initiatives. The document is a public announcement related to the company's capital raising and listing event, not a detailed financial report or regulatory filing. It does not contain comprehensive financial statements or detailed management analysis but rather serves as an announcement of the company's IPO and listing status. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes such as IPOs.
2007-01-16 English
Financial Report December 2003 32 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'Financial Report' for the 12 months ended 31 December 2003, indicating it covers a full fiscal year. It includes detailed sections such as Directors Report, Statements of Financial Performance, Statements of Financial Position, Notes to the Financial Statements, Directors Declaration, and Independent Auditors Report. The presence of comprehensive financial statements and notes confirms this is a full annual report. The length of the document (15,000 characters) and the detailed financial data further support this classification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2003
2007-01-15 English
Financial Report 31 December 2005 36 pages ?Kb
Annual Report Classification · 98% confidence The document is titled 'Financial Report' for the year ended 31 December 2005 and contains detailed financial statements such as Income Statement, Balance Sheet, Cash Flow Statement, Statement of Changes in Equity, Notes to the Financial Statements, Director's Declaration, and Independent Audit Report. It includes an Executive Report, Director's Report, and detailed financial performance and operating highlights for the year. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content and structure align with a comprehensive annual report covering company activity and full financial performance for the fiscal year. Therefore, the document fits the definition of an Annual Report (10-K). FY 2005
2007-01-15 English
Top 20 shareholders 1 page ?Kb
Major Shareholding Notification Classification · 95% confidence The document is titled 'Appendix 1A - ASX Listing application and agreement' and contains a detailed schedule of significant shareholders with their shareholdings and percentages. It mentions an updated schedule for the ASX requirement related to capital raising and vendor sell down. The content focuses on share ownership details rather than financial performance, management changes, or meeting results. The document length is 2701 characters, which is relatively short and does not contain financial statements or report narratives. This type of document aligns with notifications about major shareholdings or ownership schedules required by stock exchanges. Therefore, the most appropriate classification is 'Major Shareholding Notification' (MRQ).
2007-01-15 English
Distribution Schedule 1 page ?Kb
Regulatory Filings Classification · 90% confidence The document is titled 'Appendix 1A - ASX Listing application and agreement' and mentions an updated schedule related to ASX requirements following capital raising and vendor sell down. The content is brief (641 characters) and appears to be an attachment or schedule related to a listing application rather than a full report or detailed financial disclosure. It does not contain financial statements, management discussion, or detailed regulatory disclosures. Given the context and brevity, this is best classified as a Regulatory Filing (RNS), as it is a general regulatory announcement related to listing requirements and capital raising, not a full report or announcement of voting results or capital changes.
2007-01-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.